{"id":"placebo-air-aerosol","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108889","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a placebo formulation used in clinical trials as a control arm. It consists of aerosolized air with no active pharmaceutical ingredient and therefore produces no direct pharmacological effect. It serves to establish baseline efficacy and safety comparisons against active treatment arms in respiratory or inhalation studies.","oneSentence":"Placebo air aerosol delivers inert air via aerosol inhalation as a control comparator with no active pharmacological mechanism.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:00:32.576Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (non-therapeutic)"}]},"trialDetails":[{"nctId":"NCT05960929","phase":"PHASE3","title":"InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS","status":"RECRUITING","sponsor":"ONY","startDate":"2025-01-01","conditions":"Respiratory Distress Syndrome (Neonatal), Intubation Complication, Death; Neonatal","enrollment":220},{"nctId":"NCT04925414","phase":"PHASE4","title":"Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2023-10-01","conditions":"Migraine","enrollment":70},{"nctId":"NCT04961528","phase":"PHASE3","title":"ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-27","conditions":"Hemoptysis","enrollment":315},{"nctId":"NCT02139644","phase":"PHASE3","title":"Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-06","conditions":"Asthma","enrollment":787},{"nctId":"NCT04949386","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.","status":"UNKNOWN","sponsor":"SolAeroMed Inc.","startDate":"2021-09","conditions":"Post Acute COVID-19 Syndrome, Long COVID, COVID-19 Respiratory Infection","enrollment":48},{"nctId":"NCT04028960","phase":"PHASE2","title":"IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase","status":"TERMINATED","sponsor":"HealthPartners Institute","startDate":"2019-10-23","conditions":"Type1diabetes","enrollment":4},{"nctId":"NCT02334553","phase":"PHASE2","title":"Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma","status":"COMPLETED","sponsor":"SolAeroMed Inc.","startDate":"2015-02-06","conditions":"Asthma","enrollment":12},{"nctId":"NCT02275364","phase":"PHASE4","title":"Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-05","conditions":"Nasal Congestion","enrollment":28},{"nctId":"NCT01570062","phase":"PHASE2","title":"Cardiovascular Effects of Aerosols in Residences Study","status":"COMPLETED","sponsor":"Simon Fraser University","startDate":"2011-11","conditions":"Endothelial Dysfunction, Systemic Inflammation","enrollment":83},{"nctId":"NCT01136421","phase":"PHASE3","title":"Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2005-01","conditions":"COPD Exacerbation","enrollment":124}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo air aerosol","genericName":"placebo air aerosol","companyName":"Centre Hospitalier Universitaire de Nice","companyId":"centre-hospitalier-universitaire-de-nice","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo air aerosol delivers inert air via aerosol inhalation as a control comparator with no active pharmacological mechanism. Used for Clinical trial control arm (non-therapeutic).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}